Renowned vitreoretinal surgeon, NJRetina’s Paul Hahn, MD, PhD has brought a cutting-edge, FDA-approved implant procedure, the Argus II Retina Prosthesis system, to New Jersey.
For patients with retinitis pigmentosa (RP), you may qualify for this procedure that partially restores vision for those who have lost their sight due to this rare disorder.
Who Is This Aimed At?
The criteria for potential patients for the Argus II is:
- Those who have bare light or no light perception in both eyes due to RP
- Are 25 years or older
- Have a previous history of useful form vision
- Can commit to receiving the recommended post-implant clinical follow-up, device fitting, and low-vision rehabilitation
How Does It Work?
The retinal implant is programmed post-surgery and is intended for only one eye, typically the worse-seeing eye.
The Argus II consists of an external (wearable) and internal (surgically implanted) component. The external equipment consists of glasses, a video processing unit (VPU), and a wired cable.
The glasses hold a miniature video camera that transmits images to a pocket-sized, wearable computer for image processing. The computer transforms the images to data that are then transmitted wirelessly to the internal implant in the eye, which is also powered wirelessly by the external glasses.
Although the patient will not be able to read, drive, or recognize faces, he or she may have the power to localize objects and identify movements through flashes of light. Participants report being able to determine where surrounding people are standing, which improves their sense of social connectedness, one of the most important benefits of this device. Argus II patients have reported to be able to localize their dinner plate or a glass of water, follow the straight lines of a crosswalk, “see” the location of a loved one’s face, and identify doorways and windows.
Watch the YouTube video about Dr. Hahn's first Argus patient outcome
If you think you may be a candidate for the Argus II Retinal Prosthesis System,
please fill out our contact form.